The impact of intraocular pressure reduction on retinal ganglion cell function measured using pattern electroretinogram in eyes receiving latanoprost 0.005% versus placebo

Vision Research

Volumn 51, Issue 2, 2011, Pages 235-242

  Sehi, Mitra ^a   Grewal, Dilraj S ^a   Feuer, William J ^a   Greenfield, David S ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Glaucoma; Intraocular pressure; Latanoprost; Pattern electroretinogram; Retinal ganglion cell

Indexed keywords

LATANOPROST; PLACEBO;

ADULT; AGED; ARTICLE; CELL FUNCTION; CONTROLLED CLINICAL TRIAL; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; ELECTRORETINOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PRESSURE MEASUREMENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RETINA GANGLION CELL; TREATMENT DURATION; TREATMENT RESPONSE;

AGED; ANTIHYPERTENSIVE AGENTS; CROSS-OVER STUDIES; ELECTRORETINOGRAPHY; FEMALE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; MALE; MIDDLE AGED; OCULAR HYPERTENSION; PROSPECTIVE STUDIES; PROSTAGLANDINS F, SYNTHETIC; RETINAL GANGLION CELLS;

EID: 78651507938     PISSN: 00426989     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.visres.2010.08.036     Document Type: Article

References (54)

1. Alm A., Widengard I., Kjellgren D., Soderstrom M., Fristrom B., Heijl A., et al. Latanoprost administered once daily caused a maintained reduction of intraocular pressure in glaucoma patients treated concomitantly with timolol. British Journal of Ophthalmology 1995, 79(1):12-16.
2. Bach M., Hoffmann M.B. Update on the pattern electroretinogram in glaucoma. Optometry and Vision Science 2008, 85(6):386-395.
3. Bach M., Speidel-Fiaux A. Pattern electroretinogram in glaucoma and ocular hypertension. Documenta Ophthalmologica 1989, 73(2):173-181.
4. Bach M., Unsoeld A.S., Philippin H., Staubach F., Maier P., Walter H.S., et al. Pattern ERG as an early glaucoma indicator in ocular hypertension: A long-term, prospective study. Investigative Ophthalmology and Visual Science 2006, 47(11):4881-4887.
5. Ben-Shlomo G., Bakalash S., Lambrou G.N., Latour E., Dawson W.W., Schwartz M., et al. Pattern electroretinography in a rat model of ocular hypertension: Functional evidence for early detection of inner retinal damage. Experimental Eye Research 2005, 81(3):340-349.
6. Bito L.Z., Stjernschantz J., Resul B., Miranda O.C., Basu S. The ocular effects of prostaglandins and the therapeutic potential of a new PGF2 alpha analog, PhXA41 (latanoprost), for glaucoma management. Journal of Lipid Mediators 1993, 6(1-3):535-543.
7. Bowd C., Tafreshi A., Vizzeri G., Zangwill L.M., Sample P.A., Weinreb R.N. Repeatability of pattern electroretinogram measurements using a new paradigm optimized for glaucoma detection. Journal of Glaucoma 2009, 18(6):437-442.
8. Bowd C., Vizzeri G., Tafreshi A., Zangwill L.M., Sample P.A., Weinreb R.N. Diagnostic accuracy of pattern electroretinogram optimized for glaucoma detection. Ophthalmology 2009, 116(3):437-443.
9. Camras C.B. Comparison of latanoprost and timolol in patients with ocular hypertension and glaucoma: A six-month masked, multicenter trial in the United States. The United States latanoprost study group. Ophthalmology 1996, 103(1):138-147.
10. Cheng J.W., Cai J.P., Wei R.L. Meta-analysis of medical intervention for normal tension glaucoma. Ophthalmology 2009, 116(7):1243-1249.
11. Demb J.B. Functional circuitry of visual adaptation in the retina. Journal of Physiology 2008, 586(Pt 18):4377-4384.
12. Dinslage S., Hueber A., Diestelhorst M., Krieglstein G. The influence of latanoprost 0.005% on aqueous humor flow and outflow facility in glaucoma patients: A double-masked placebo-controlled clinical study. Graefes Archive for Clinical and Experimental Ophthalmology 2004, 242(8):654-660.
13. Drance S.M., Crichton A., Mills R.P. Comparison of the effect of latanoprost 0.005% and timolol 0.5% on the calculated ocular perfusion pressure in patients with normal-tension glaucoma. American Journal of Ophthalmology 1998, 125(5):585-592.
14. Falsini, B., Marangoni, D., Salgarello, T., Stifano, G., Montrone, L., Campagna, F., et al. (2008). Structure-function relationship in ocular hypertension and glaucoma: Interindividual and interocular analysis by OCT and pattern ERG. Graefes Archive for Clinical and Experimental Ophthalmology.
15. Fredette M.J., Anderson D.R., Porciatti V., Feuer W. Reproducibility of pattern electroretinogram in glaucoma patients with a range of severity of disease with the new glaucoma paradigm. Ophthalmology 2008, 115(6):957-963.
16. Fristrom B., Nilsson S.E. Interaction of PhXA41, a new prostaglandin analogue, with pilocarpine. A study on patients with elevated intraocular pressure. Archives of Ophthalmology 1993, 111(5):662-665.
17. Gherghel D., Orgul S., Gugleta K., Gekkieva M., Flammer J. Relationship between ocular perfusion pressure and retrobulbar blood flow in patients with glaucoma with progressive damage. American Journal of Ophthalmology 2000, 130(5):597-605.
18. Hood D.C., Xu L., Thienprasiddhi P., Greenstein V.C., Odel J.G., Grippo T.M., et al. The pattern electroretinogram in glaucoma patients with confirmed visual field deficits. Investigative Ophthalmology and Visual Science 2005, 46(7):2411-2418.
19. Hotehama Y., Mishima H.K., Kitazawa Y., Masuda K. Ocular hypotensive effect of PhXA41 in patients with ocular hypertension or primary open-angle glaucoma. Japanese Journal of Ophthalmology 1993, 37(3):270-274.
20. Johnson E.C., Morrison J.C. Friend or foe? Resolving the impact of glial responses in glaucoma. Journal of Glaucoma 2009, 18(5):341-353.
21. Johnson M.A., Drum B.A., Quigley H.A., Sanchez R.M., Dunkelberger G.R. Pattern-evoked potentials and optic nerve fiber loss in monocular laser-induced glaucoma. Investigative Ophthalmology and Visual Science 1989, 30(5):897-907.
22. Kiuchi T., Motoyama Y., Oshika T. Influence of ocular hypotensive eyedrops on intraocular pressure fluctuation with postural change in eyes with normal-tension glaucoma. American Journal of Ophthalmology 2007, 143(4):693-695.
23. Marx M.S., Podos S.M., Bodis-Wollner I., Lee P.Y., Wang R.F., Severin C. Signs of early damage in glaucomatous monkey eyes: Low spatial frequency losses in the pattern ERG and VEP. Experimental Eye Research 1988, 46(2):173-184.
24. Mishima H.K., Kiuchi Y., Takamatsu M., Racz P., Bito L.Z. Circadian intraocular pressure management with latanoprost: Diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow. Survey of Ophthalmology 1997, 41(Suppl. 2):S139-S144.
25. Nagasubramanian S., Sheth G.P., Hitchings R.A., Stjernschantz J. Intraocular pressure-reducing effect of PhXA41 in ocular hypertension. Comparison of dose regimens. Ophthalmology 1993, 100(9):1305-1311.
26. Nesher R., Trick G.L., Kass M.A., Gordon M.O. Steady-state pattern electroretinogram following long term unilateral administration of timolol to ocular hypertensive subjects. Documenta Ophthalmologica 1990, 75(2):101-109.
27. Parisi V., Miglior S., Manni G., Centofanti M., Bucci M.G. Clinical ability of pattern electroretinograms and visual evoked potentials in detecting visual dysfunction in ocular hypertension and glaucoma. Ophthalmology 2006, 113(2):216-228.
28. Porciatti V., Falsini B., Brunori S., Colotto A., Moretti G. Pattern electroretinogram as a function of spatial frequency in ocular hypertension and early glaucoma. Documenta Ophthalmologica 1987, 65(3):349-355.
29. Porciatti V., Nagaraju M. Head-up tilt lowers IOP and improves RGC dysfunction in glaucomatous DBA/2J mice. Experimental Eye Research 2010, 90(3):452-460.
30. Porciatti V., Sorokac N., Buchser W. Habituation of retinal ganglion cell activity in response to steady state pattern visual stimuli in normal subjects. Investigative Ophthalmology and Visual Science 2005, 46(4):1296-1302.
31. Porciatti V., Ventura L.M. Normative data for a user-friendly paradigm for pattern electroretinogram recording. Ophthalmology 2004, 111(1):161-168.
32. Price M.J., Drance S.M., Price M., Schulzer M., Douglas G.R., Tansley B. The pattern electroretinogram and visual-evoked potential in glaucoma. Graefes Archive for Clinical and Experimental Ophthalmology 1988, 226(6):542-547.
33. Resul B., Stjernschantz J., No K., Liljebris C., Selen G., Astin M., et al. Phenyl-substituted prostaglandins: Potent and selective antiglaucoma agents. Journal of Medicinal Chemistry 1993, 36(2):243-248.
34. Resul B., Stjernschantz J., Selen G., Bito L. Structure-activity relationships and receptor profiles of some ocular hypotensive prostanoids. Survey of Ophthalmology 1997, 41(Suppl. 2):S47-S52.
35. Ringens P.J., Vijfvinkel-Bruinenga S., van Lith G.H. The pattern-elicited electroretinogram. I. A tool in the early detection of glaucoma?. Ophthalmologica 1986, 192(3):171-175.
36. Riva C.E., Salgarello T., Logean E., Colotto A., Galan E.M., Falsini B. Flicker-evoked response measured at the optic disc rim is reduced in ocular hypertension and early glaucoma. Investigative Ophthalmology and Visual Science 2004, 45(10):3662-3668.
37. Rulo A.H., Greve E.L., Geijssen H.C., Hoyng P.F. Reduction of intraocular pressure with treatment of latanoprost once daily in patients with normal-pressure glaucoma. Ophthalmology 1996, 103(8):1276-1282.
38. Sehi, M., Grewal, D. S., Goodkin, M. L., & Greenfield, D. S. (in press). Reversal of retinal ganglion cell dysfunction following surgical reduction of intraocular pressure. Ophthalmology.
39. Sehi M., Pinzon-Plazas M., Feuer W.J., Greenfield D.S. Relationship between pattern electroretinogram, standard automated perimetry, and optic nerve structural assessments. Journal of Glaucoma 2009, 18(8):608-617.
40. Tytla M.E., Trope G.E., Buncic J.R. Flicker sensitivity in treated ocular hypertension. Ophthalmology 1990, 97(1):36-43.
41. Varma R., Peeples P., Walt J.G., Bramley T.J. Disease progression and the need for neuroprotection in glaucoma management. American Journal of Managed Care 2008, 14(Suppl. 1):S15-S19.
42. Ventura L.M., Porciatti V. Restoration of retinal ganglion cell function in early glaucoma after intraocular pressure reduction: A pilot study. Ophthalmology 2005, 112(1):20-27.
43. Ventura L.M., Porciatti V., Ishida K., Feuer W.J., Parrish R.K. Pattern electroretinogram abnormality and glaucoma. Ophthalmology 2005, 112(1):10-19.
44. Ventura L.M., Sorokac N., De Los Santos R., Feuer W.J., Porciatti V. The relationship between retinal ganglion cell function and retinal nerve fiber thickness in early glaucoma. Investigative Ophthalmology and Visual Science 2006, 47(9):3904-3911.
45. Villumsen J., Alm A. PhXA34 - A prostaglandin F2 alpha analogue. Effect on intraocular pressure in patients with ocular hypertension. British Journal of Ophthalmology 1992, 76(4):214-217.
46. Viswanathan S., Frishman L.J., Robson J.G. The uniform field and pattern ERG in macaques with experimental glaucoma: Removal of spiking activity. Investigative Ophthalmology and Visual Science 2000, 41(9):2797-2810.
47. Viswanathan S., Frishman L.J., Robson J.G., Harwerth R.S., Smith E.L. The photopic negative response of the macaque electroretinogram: Reduction by experimental glaucoma. Investigative Ophthalmology and Visual Science 1999, 40(6):1124-1136.
48. Viswanathan S., Frishman L.J., Robson J.G., Walters J.W. The photopic negative response of the flash electroretinogram in primary open angle glaucoma. Investigative Ophthalmology and Visual Science 2001, 42(2):514-522.
49. Watson P., Stjernschantz J. A six-month, randomized, double-masked study comparing latanoprost with timolol in open-angle glaucoma and ocular hypertension. The latanoprost study group. Ophthalmology 1996, 103(1):126-137.
50. Weinreb R.N. Enhancement of scleral macromolecular permeability with prostaglandins. Transactions of the American Ophthalmological Society 2001, 99:319-343.
51. Weinreb R.N., Khaw P.T. Primary open-angle glaucoma. Lancet 2004, 363(9422):1711-1720.
52. Wittstrom E., Schatz P., Lovestam-Adrian M., Ponjavic V., Bergstrom A., Andreasson S. Improved retinal function after trabeculectomy in glaucoma patients. Graefes Archive for Clinical and Experimental Ophthalmology 2010, 248(4):485-495.
53. Yang A., Swanson W.H. A new pattern electroretinogram paradigm evaluated in terms of user friendliness and agreement with perimetry. Ophthalmology 2007, 114(4):671-679.
54. Ziai N., Dolan J.W., Kacere R.D., Brubaker R.F. The effects on aqueous dynamics of PhXA41, a new prostaglandin F2 alpha analogue, after topical application in normal and ocular hypertensive human eyes. Archives of Ophthalmology 1993, 111(10):1351-1358.